HKD 2.81
(-0.35%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 434.82 Million CNY | 75.93% |
2022 | 234.39 Million CNY | -26.35% |
2021 | 304.64 Million CNY | 22.51% |
2020 | 259.78 Million CNY | 26.06% |
2019 | 191.17 Million CNY | 38.38% |
2018 | 143.54 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q3 | 83.57 Million CNY | -14.21% |
2023 Q2 | 97.41 Million CNY | 0.0% |
2023 Q1 | 97.41 Million CNY | 64.88% |
2023 FY | - CNY | 75.93% |
2023 Q4 | 83.57 Million CNY | 0.0% |
2022 Q2 | 74.84 Million CNY | 0.0% |
2022 Q4 | 59.08 Million CNY | 0.0% |
2022 Q3 | 59.08 Million CNY | -21.06% |
2022 FY | - CNY | -26.35% |
2022 Q1 | 74.84 Million CNY | 12.0% |
2021 Q1 | 76.57 Million CNY | 9.18% |
2021 FY | - CNY | 22.51% |
2021 Q4 | 66.82 Million CNY | 0.0% |
2021 Q3 | 66.82 Million CNY | -12.73% |
2021 Q2 | 76.57 Million CNY | 0.0% |
2020 Q4 | 70.13 Million CNY | 0.0% |
2020 Q2 | 42.45 Million CNY | 0.0% |
2020 Q1 | 42.45 Million CNY | 0.0% |
2020 Q3 | 70.13 Million CNY | 65.22% |
2020 FY | - CNY | 26.06% |
2019 FY | - CNY | 38.38% |
2018 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aidigong Maternal & Child Health Limited | 68.84 Million HKD | -531.571% |
UMP Healthcare Holdings Limited | 161.98 Million HKD | -168.44% |
Human Health Holdings Limited | 104.06 Million HKD | -317.843% |
EuroEyes International Eye Clinic Limited | 292.1 Million HKD | -48.859% |
Kato (Hong Kong) Holdings Limited | 133.61 Million HKD | -225.44% |
Bamboos Health Care Holdings Limited | 52.75 Million HKD | -724.186% |
Beijing Health (Holdings) Limited | -44.19 Million HKD | 1083.965% |
C-MER Eye Care Holdings Limited | 359.88 Million HKD | -20.824% |
Town Health International Medical Group Limited | 53.5 Million HKD | -712.74% |
Medicskin Holdings Limited | 6.77 Million HKD | -6317.119% |
Hang Chi Holdings Limited | 81.58 Million HKD | -432.957% |